Akinyemiju Tomi, Wilson Lauren E, Deveaux April, Aslibekyan Stella, Cushman Mary, Gilchrist Susan, Safford Monika, Judd Suzanne, Howard Virginia
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27701, USA.
Duke Cancer Institute, Duke University, Durham, NC 27710, USA.
Cancers (Basel). 2020 Jun 26;12(6):1695. doi: 10.3390/cancers12061695.
Among 29,701 Black and White participants aged 45 years and older in the Reasons forGeographic and Racial Difference in Stroke (REGARDS) study, allostatic load (AL) was defined asthe sum score of established baseline risk-associated biomarkers for which participants exceeded aset cutoff point. Cox proportional hazard regression was utilized to determine the association of ALscore with all-cause and cancer-specific mortality, with analyses stratified by body-mass index, agegroup, and race. At baseline, Blacks had a higher AL score compared with Whites (Black mean ALscore: 2.42, SD: 1.50; White mean AL score: 1.99, SD: 1.39; < 0.001). Over the follow-up period,there were 4622 all-cause and 1237 cancer-specific deaths observed. Every unit increase in baselineAL score was associated with a 24% higher risk of all-cause (HR: 1.24, 95% CI: 1.22, 1.27) and a 7%higher risk of cancer-specific mortality (HR: 1.07, 95% CI: 1.03, 1.12). The association of AL withoverall- and cancer-specific mortality was similar among Blacks and Whites and across age-groups,however the risk of cancer-specific mortality was higher among normal BMI than overweight orobese participants. In conclusion, a higher baseline AL score was associated with increased risk ofall-cause and cancer-specific mortality among both Black and White participants. Targetedinterventions to patient groups with higher AL scores, regardless of race, may be beneficial as astrategy to reduce all-cause and cancer-specific mortality.
在中风地理和种族差异原因(REGARDS)研究中,对29701名45岁及以上的黑人和白人参与者进行了研究,将应激负荷(AL)定义为参与者超过设定临界值的既定基线风险相关生物标志物的总分。采用Cox比例风险回归来确定AL评分与全因死亡率和癌症特异性死亡率之间的关联,并按体重指数、年龄组和种族进行分层分析。在基线时,黑人的AL评分高于白人(黑人平均AL评分:2.42,标准差:1.50;白人平均AL评分:1.99,标准差:1.39;<0.001)。在随访期间,观察到4622例全因死亡和1237例癌症特异性死亡。基线AL评分每增加一个单位,全因死亡风险就会增加24%(风险比:1.24,95%置信区间:1.22,1.27),癌症特异性死亡风险会增加7%(风险比:1.07,95%置信区间:1.03,1.12)。黑人与白人以及不同年龄组中,AL与全因死亡率和癌症特异性死亡率之间的关联相似,然而,正常体重指数参与者的癌症特异性死亡风险高于超重或肥胖参与者。总之,较高的基线AL评分与黑人和白人参与者的全因死亡率和癌症特异性死亡风险增加相关。针对AL评分较高的患者群体进行有针对性的干预,无论种族如何,作为降低全因死亡率和癌症特异性死亡率的策略可能是有益的。